Benzinga | Mar 16, 2021 07:03AM EDT

HC Wainwright & Co. Maintains Buy on Bausch Health Companies, Raises Price Target to $55

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Bausch Health Companies (NYSE:BHC) with a Buy and raises the price target from $50 to $55.